Treatment with tenofovir alafenamide (TAF) for pregnant women with active chronic hepatitis B (CHB) infection, when administered throughout or initiated early in pregnancy, is effective and safe in both mothers and infants, according to a study.
New drug applications approved by US FDA as of 01-15 December 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Menopausal women who consume ultra-processed foods in high amounts appear to experience worse vasomotor, sexual, and somatic symptoms, as well as poorer memory and concentration, according to a study. On the other hand, high intakes of vegetables confer protection against menopausal symptoms and contribute to a better quality of life.
Lifestyle interventions or bariatric surgery leading to preconceptional weight loss effectively reduces the risk of hypertensive disorders of pregnancy (HDP), such as pregnancy-induced hypertension (PIH) and pre-eclampsia (PE), reports a recent meta-analysis.
Assisted reproductive technology (ART) is both safe and effective in women with ulcerative colitis and medically managed Crohn’s disease (CD), with comparable pregnancy and live birth rates to those of the general population, a study has shown.